font size
Sign in


Breaking through the Sequencing Bottleneck

Podcast: July 28, 2014

The rapid decline in the cost of genome sequencing is creating an information technology bottleneck as servers designed for general purposes have proven a bit clunky at assembling and analyzing the output from sequencers. Edico Genome thinks it has an answer with its DRAGEN Bio-IT Processor, designed specifically for processing genomic data. We spoke to Pieter van Rooyen, CEO of Edico about tackling the computing bottleneck, how the company plans to use the $10 million in funding it just raised, and what the implications of a dramatic reduction in time and cost will have on how sequencing is used. Read More
Todays Stories
Podcast The Changing Patent Landscape for Genome 2.0

Gareth Williams, partner with Marks & Clerk, discusses his firm's new report on patents related to personalized medicine, sequencing, and synthetic biology; where the sources of innovation are today; and the changing landscape for intellectual property.

By the numbers AbbVie Inches Closer to Acquiring Shire

The board of Shire Pharmaceuticals has entered into negotiations with AbbVie on a potential takeover of the U.K. specialty pharmaceutical after AbbVie sweetened its offer to $53.6 billion over the weekend. If successful, it will be the largest biopharma M&A deal since the megamergers of 2009, and the largest tax inversion deal by a drugmaker to date.